More on IPXL

- Summary
- Chart
- Profile
- Historical


- Earnings
- Ratings
- Holders
- FDA Archive


Income Statement
Balance Sheet
Cash Flow Statement

Upcoming Events

- Earnings (8/6/15 *Est.)


- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks

IPXL Balance Sheet

Click line-items for a historical chart and %
Current assets:
Cash and cash equivalents 200.47M
Short-term investments 242.05M
Accounts receivable, net 152.29M
Inventory, net 86.15M
Deferred product manufacturing costs
Deferred income taxes 51.84M
Prepaid expenses and other current assets 18.22M
Total current assets 751.01M
Property, plant and equipment, net 191.27M
Deferred product manufacturing costs
Deferred income taxes, net 41.5M
Other assets 52.51M
Goodwill 27.57M
Total assets 1.09B
Current liabilities:
Accounts payable 33.46M
Accrued expenses 121.45M
Accrued income taxes payable
Accrued profit sharing and royalty expenses 13.61M
Deferred revenue 1.63M
Total current liabilities 170.15M
Deferred revenue 3.47M
Other liabilities 30.06M
Total liabilities 203.67M
Commitments and contingencies (Note 8) 0
Stockholders' equity:
Preferred Stock, $ 0.01 par value, 2,000,000 shares authorized, 0 shares outstanding at June 30, 2011 and December 31, 2010 0
Common stock, $ 0.01 par value, 90,000,000 shares authorized and 65,872,062 and 64,721,041 shares issued at June 30, 2011 and December 31, 2010, respectively 710K
Additional paid-in capital 360.52M
Treasury stock-243,729 shares -2.16M
Accumulated other comprehensive income -1.67M
Retained earnings 531.11M
Stockholders' Equity Attributable to Parent, Total
Noncontrolling interest
Total stockholders' equity 888.5M
Total liabilities and stockholders' equity 1.09B